Semaglutide · 2026-08-13
ClinicalTrials.gov record NCT07087795
Active, not recruiting at the retained observation.
Open attributed record →Official registry phase
Phase 1 peptide trials
25 selected ClinicalTrials.gov records carrying the official Phase 1 designation. Phase is reported exactly as supplied by the retained registry version; records without a supplied phase are not inferred into this page.
Registry records
25 selected records.
Connected peptides
9 profiles.
Source boundary
ClinicalTrials.gov phase field.
Attributed registry records
Selected records
Tirzepatide · 2026-08-12
ClinicalTrials.gov record NCT07463846
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-07
ClinicalTrials.gov record NCT07313761
Completed at the retained observation.
Open attributed record →Tirzepatide · 2026-07-28
ClinicalTrials.gov record NCT07559500
Recruiting at the retained observation.
Open attributed record →Afamelanotide · 2026-07-27
ClinicalTrials.gov record NCT06388642
Completed at the retained observation.
Open attributed record →Petrelintide · 2026-07-06
ClinicalTrials.gov record NCT07682818
Recruiting at the retained observation.
Open attributed record →Glucagon · 2026-03-30
ClinicalTrials.gov record NCT02817659
Active, not recruiting at the retained observation.
Open attributed record →TB-500 · 2026-03-23
ClinicalTrials.gov record NCT07487363
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2021-11-22
ClinicalTrials.gov record NCT03357380
Completed at the retained observation.
Open attributed record →Semaglutide · 2020-12-24
ClinicalTrials.gov record NCT03842202
Completed at the retained observation.
Open attributed record →Leuprolide · 2019-07-24
ClinicalTrials.gov record NCT00669162
Completed at the retained observation.
Open attributed record →Semaglutide · 2019-06-19
ClinicalTrials.gov record NCT03466567
Completed at the retained observation.
Open attributed record →Afamelanotide · 2018-08-16
ClinicalTrials.gov record NCT03634137
Completed at the retained observation.
Open attributed record →Semaglutide · 2018-06-13
ClinicalTrials.gov record NCT02064348
Completed at the retained observation.
Open attributed record →Semaglutide · 2018-04-18
ClinicalTrials.gov record NCT02146079
Completed at the retained observation.
Open attributed record →Semaglutide · 2017-12-02
ClinicalTrials.gov record NCT02079870
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-06-01
ClinicalTrials.gov record NCT00225420
Completed at the retained observation.
Open attributed record →Semaglutide · 2017-04-04
ClinicalTrials.gov record NCT02022254
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-05-25
ClinicalTrials.gov record NCT00943956
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-01-29
ClinicalTrials.gov record NCT00631527
Completed at the retained observation.
Open attributed record →Liraglutide · 2014-12-09
ClinicalTrials.gov record NCT01507389
Completed at the retained observation.
Open attributed record →Leuprolide · 2014-05-14
ClinicalTrials.gov record NCT01160328
Completed at the retained observation.
Open attributed record →Liraglutide · 2014-02-27
ClinicalTrials.gov record NCT01550653
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-06-24
ClinicalTrials.gov record NCT00003394
Completed at the retained observation.
Open attributed record →Leuprolide · 2012-03-19
ClinicalTrials.gov record NCT00653757
Completed at the retained observation.
Open attributed record →